GoodRx is monitoring seven potential FDA drug approvals in 2025, including a possible expanded label for Ozempic. Here are this year's most anticipated approval decisions, according to a GoodRx ...
In a disclaimer, GoodRx noted that the list was created by prioritizing "first-in-class medications and vaccines that are expected to have a significant impact on human health." "This was defined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback